{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:13:15Z","timestamp":1791184395784,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Singapore National Medical Research Council (NMRC) (NMRC\/CG\/NUHCS\/2010\/Theme 4: Biomarkers and Management of Cardiovascular Disease)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Proteomics"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jprot.2013.10.009","type":"journal-article","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T04:35:30Z","timestamp":1381898130000},"page":"337-345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Proteomics discovery of biomarkers for mitral regurgitation caused by mitral valve prolapse"],"prefix":"10.1016","volume":"94","author":[{"given":"Hwee Tong","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieng H.","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Consolacion","family":"Dolor-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5470-4554","authenticated-orcid":false,"given":"James Wei-Luen","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur Mark","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxey C.M.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jprot.2013.10.009_bb0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-med-022811-091602","article-title":"Mitral valve prolapse","volume":"63","author":"Guy","year":"2012","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jprot.2013.10.009_bb0010","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJM199611073351902","article-title":"Clinical outcome of mitral regurgitation due to flail leaflets","volume":"335","author":"Ling","year":"1996","journal-title":"N Eng J Med"},{"key":"10.1016\/j.jprot.2013.10.009_bb0015","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/CIRCULATIONAHA.108.802314","article-title":"Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation","volume":"119","author":"Kang","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jprot.2013.10.009_bb0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jcmg.2009.09.029","article-title":"Reproducibility of proximal isovelocity surface area, vena contracta, and regurgitant jet area for assessment of mitral regurgitation severity","volume":"3","author":"Biner","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jprot.2013.10.009_bb0025","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"33","author":"Vahanian","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jprot.2013.10.009_bb0030","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jacc.2009.06.013","article-title":"Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation","volume":"54","author":"Pizarro","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jprot.2013.10.009_bb0035","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1074\/mcp.R800007-MCP200","article-title":"The role of proteomics in clinical cardiovascular biomarker discovery","volume":"7","author":"Edwards","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2013.10.009_bb0040","first-page":"250","article-title":"Therapeutic potential of the plasma proteome","volume":"5","author":"Lathrop","year":"2003","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.jprot.2013.10.009_bb0045","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/prca.200900066","article-title":"Differential protein expression between normal, early-stage, and late-stage myxomatous mitral valves from dogs","volume":"3","author":"Lacerda","year":"2009","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.jprot.2013.10.009_bb0050","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/eurheartj\/ehq222","article-title":"Degenerative mitral valve regurgitation: best practice revolution","volume":"31","author":"Adams","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jprot.2013.10.009_bb0055","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jprot.2011.01.013","article-title":"\u201cProteomineering\u201d or not? The debate on biomarker discovery in sera continues","volume":"74","author":"Di Girolamo","year":"2011","journal-title":"J Proteomics"},{"key":"10.1016\/j.jprot.2013.10.009_bb0060","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1074\/mcp.M700483-MCP200","article-title":"Quantitative and temporal proteome analysis of butyrate-treated colorectal cancer cells","volume":"7","author":"Tan","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2013.10.009_bb0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-61779-012-6_13","article-title":"iTRAQ labeling coupled with LC-MALDI mass spectrometry for monitoring temporal response of colorectal cancer cells to butyrate treatment","volume":"716","author":"Tan","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jprot.2013.10.009_bb0070","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/pmic.200300721","article-title":"The International Protein Index: an integrated database for proteomics experiments","volume":"4","author":"Kersey","year":"2004","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2013.10.009_bb0075","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1021\/pr201014h","article-title":"Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer","volume":"11","author":"Loei","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2013.10.009_bb0080","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","article-title":"The human plasma proteome: history, character, and diagnostic prospects","volume":"1","author":"Anderson","year":"2002","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2013.10.009_bb0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jprot.2008.05.002","article-title":"The ProteoMiner in the proteomic arena: a non-depleting tool for discovering low-abundance species","volume":"71","author":"Boschetti","year":"2008","journal-title":"J Proteomics"},{"key":"10.1016\/j.jprot.2013.10.009_bb0090","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/pmic.200800485","article-title":"Investigating sample pooling strategies for DIGE experiments to address biological variability","volume":"9","author":"Karp","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2013.10.009_bb0095","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1002\/elps.200900210","article-title":"The consequences of sample pooling in proteomics: an empirical study","volume":"30","author":"Diz","year":"2009","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jprot.2013.10.009_bb0100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/ars.2009.2793","article-title":"Haptoglobin: basic and clinical aspects","volume":"12","author":"Levy","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jprot.2013.10.009_bb0105","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.1980.03300450023014","article-title":"The predictive value of serum haptoglobin in hemolytic disease","volume":"243","author":"Marchand","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.jprot.2013.10.009_bb0110","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0735-1097(98)00294-0","article-title":"Mechanisms of hemolysis after mitral valve repair: assessment by serial echocardiography","volume":"32","author":"Yeo","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jprot.2013.10.009_bb0115","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0735-1097(95)00403-3","article-title":"Mechanisms of hemolysis with mitral prosthetic regurgitation. Study using transesophageal echocardiography and fluid dynamic simulation","volume":"27","author":"Garcia","year":"1996","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl. 1","key":"10.1016\/j.jprot.2013.10.009_bb0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2249.1995.tb06151.x","article-title":"Activation and recruitment of neutrophil leukocytes","volume":"101","author":"Baggiolini","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jprot.2013.10.009_bb0125","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1096\/fasebj.10.11.8836048","article-title":"Leukocyte-derived growth factor links the PDGF and CXC chemokine families of peptides","volume":"10","author":"Iida","year":"1996","journal-title":"FASEB J"},{"key":"10.1016\/j.jprot.2013.10.009_bb0130","first-page":"151","article-title":"Biochemistry of alpha granule proteins","volume":"22","author":"Holt","year":"1985","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jprot.2013.10.009_bb0135","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1128\/IAI.70.12.6524-6533.2002","article-title":"Antimicrobial peptides from human platelets","volume":"70","author":"Tang","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.jprot.2013.10.009_bb0140","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1160\/TH07-01-0066","article-title":"Platelet-derived chemokines in vascular biology","volume":"97","author":"von Hundelshausen","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jprot.2013.10.009_bb0145","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJM198511213132101","article-title":"Echocardiographically documented mitral-valve prolapse. Long-term follow-up of 237 patients","volume":"313","author":"Nishimura","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jprot.2013.10.009_bb0150","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.CIR.0000028933.34260.09","article-title":"Natural history of asymptomatic mitral valve prolapse in the community","volume":"106","author":"Avierinos","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jprot.2013.10.009_bb0155","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/01.CIR.63.3.552","article-title":"Platelets, thromboembolism and mitral valve prolapse","volume":"63","author":"Walsh","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.jprot.2013.10.009_bb0160","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/S0735-1097(97)00380-X","article-title":"Relation between mitral regurgitation and platelet activation","volume":"30","author":"Tse","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jprot.2013.10.009_bb0165","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0049-3848(96)00138-7","article-title":"Platelet and blood clotting activation in patients with mitral valve prolapse","volume":"83","author":"Martini","year":"1996","journal-title":"Thromb Res"},{"key":"10.1016\/j.jprot.2013.10.009_bb0170","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.2460\/ajvr.2000.61.1248","article-title":"Platelet aggregation in dogs with mitral valve regurgitation","volume":"61","author":"Tanaka","year":"2000","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.jprot.2013.10.009_bb0175","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.rvsc.2008.07.019","article-title":"Changes in platelet function in Dachshunds with early stages of myxomatous mitral valve disease","volume":"86","author":"Moesgaard","year":"2009","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.jprot.2013.10.009_bb0180","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1939-1676.2003.tb02500.x","article-title":"Decreased platelet function in Cavalier King Charles Spaniels with mitral valve regurgitation","volume":"17","author":"Tarnow","year":"2003","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jprot.2013.10.009_bb0185","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1939-1676.2005.tb02720.x","article-title":"Dogs with heart diseases causing turbulent high-velocity blood flow have changes in platelet function and von Willebrand factor multimer distribution","volume":"19","author":"Tarnow","year":"2005","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.jprot.2013.10.009_bb0190","doi-asserted-by":"crossref","first-page":"18B","DOI":"10.1016\/S0828-282X(06)70982-5","article-title":"Complement activity and pharmacological inhibition in cardiovascular disease","volume":"22","author":"Theroux","year":"2006","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jprot.2013.10.009_bb0195","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000184699","article-title":"Diseases associated with the low copy number of the C4B gene encoding C4, the fourth component of complement","volume":"123","author":"Szilagyi","year":"2008","journal-title":"Cytogenet Genome Res"},{"key":"10.1016\/j.jprot.2013.10.009_bb0200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/intimm\/dxm117","article-title":"Low complement C4B gene copy number predicts short-term mortality after acute myocardial infarction","volume":"20","author":"Blasko","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.jprot.2013.10.009_bb0205","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1440-1746.2010.06436.x","article-title":"CXCL5 plasma levels decrease in patients with chronic liver disease","volume":"26","author":"Tacke","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jprot.2013.10.009_bb0210","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1158\/0008-5472.CAN-07-3217","article-title":"Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth","volume":"68","author":"Ebos","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jprot.2013.10.009_bb0215","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1093\/ndt\/gfr485","article-title":"Circulating microRNA expression is reduced in chronic kidney disease","volume":"26","author":"Neal","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jprot.2013.10.009_bb0220","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jns.2010.02.024","article-title":"Decreased level of 5-methyltetrahydrofolate: a potential biomarker for pre-symptomatic amyotrophic lateral sclerosis","volume":"293","author":"Zhang","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jprot.2013.10.009_bb0225","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1371\/journal.pone.0000647","article-title":"Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression","volume":"2","author":"Mochel","year":"2007","journal-title":"PLoS One"}],"container-title":["Journal of Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391913005186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391913005186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T05:57:32Z","timestamp":1646805452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874391913005186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":45,"alternative-id":["S1874391913005186"],"URL":"https:\/\/doi.org\/10.1016\/j.jprot.2013.10.009","relation":{},"ISSN":["1874-3919"],"issn-type":[{"value":"1874-3919","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomics discovery of biomarkers for mitral regurgitation caused by mitral valve prolapse","name":"articletitle","label":"Article Title"},{"value":"Journal of Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jprot.2013.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}